SCHEMBL10816711

SCHEMBL10816711

CCCCCCOC(=O)OCCCOC(OC(=O)OCCCCCC)n1cnc2c(N(C)C)ncnc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ADA P00813 4/20 0.36
▸ PDE2A O00408 3/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ CCNB2 O95067 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10816337 0.85 CYP1A2 (0.43) CYP1A2CYP2D6ADAPDE2ACYP3A4
SCHEMBL10814378 0.84 CCNB2 (0.43) CYP1A2ADAPDE2ACYP3A4PDE4A
SCHEMBL10817431 0.82 ADA (0.47) CYP1A2ADAPDE2ACYP3A4PDE4A
SCHEMBL10815169 0.79 ALDH1A1 (0.31) CYP1A2ALDH1A1TSHR
SCHEMBL10816715 0.77 CYP2D6 (0.45) CYP1A2CYP2D6MAPK1CYP3A4
SCHEMBL10814393 0.75 HK1 (0.39) CYP2D6CYP3A4ALDH1A1CDK1CCNB1
SCHEMBL10813829 0.74 ADORA2A (0.45) CYP1A2ADAPDE2ACYP3A4PDE4A
SCHEMBL10813330 0.72 CYP1A2 (0.36) CYP1A2CYP2D6MAPK1CYP3A4ALDH1A1
SCHEMBL10815977 0.69 CDK5 (0.35) —
SCHEMBL10818088 0.68 CDC20 (0.35) MAPK1CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0105135-B1 SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS SYNTEX (U.S.A.) INC. (US) 1987-03-18 — — EP disclosed
US-4609661-A HERPES VIRUS SYNTEX (U.S.A.) INC. (US) 1986-09-02 — — US disclosed
US-4556659-A Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1985-12-03 — — US disclosed
EP-0105135-A1 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-11 — — EP disclosed
Send feedback